Mammoth Blood in the ER?

A 35,000-year old woolly mammoth blood protein may aid in contemporary medical procedures.

Written byRachel Nuwer
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Woolly Mammoth blood may lend clues to modern medicine.DEREK K MILLER, FLICKR

A cold-tolerant blood protein of the now-extinct woolly mammoth may be the next best thing for surgeries requiring doctors to induce artificial hypothermia, a medical treatment that reduces the risk of ischemic tissue injury after periods of insufficient blood flow.

Among other adaptations to the cold climates mammoths survived during the Pleistocene ice age more than 1 million years ago, the elephant-like mammals accumulated genetic mutations in their hemoglobin gene, which encodes the blood protein that transports oxygen from the lungs to the rest of the body. To compare the pre-historic hemoglobin with that of modern elephants, scientists synthesized the blood protein in the laboratory by using fragmented DNA sequences from three different 25,000 to 43,000 year-old Siberian mammoths. The resulting hemoglobin, described in Biochemistry, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies